BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 1998
View Archived Issues
Aryl C-glycosides as selectin inhibitors jointly developed by Sankyo, Glycomed
Read More
SmithKline Beecham describes new cannabinoid receptor agonists
Read More
Lipid-lowering ACAT inhibitors claimed in patent literature by Yakult Honsha
Read More
New sigma-receptor ligands presented by Sumitomo
Read More
Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy
Read More
Merck's new ET receptor antagonists
Read More
CardioGenesis, Eclipse Surgical Technologies to merge
Read More
Step taken toward European protection for AltaRex's fundamental technology platform
Read More
Another merger announced: Cell Pathways acquires Tseng Labs
Read More
Bayer announces setback in AD drug development
Read More
NIAID to sponsor trials of female-controlled topical microbicide; FDA gives green light to study
Read More
Angiotech study of micellar paclitaxel in MS well under way
Read More
Irreversible inactivators of EGF receptor TK hold promise as antitumor agents
Read More
Nortran advances development of novel cough remedy
Read More
Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting
Read More
Chinese researchers report that synthetic calcium antagonist improves memory dysfunction
Read More
Licensing opportunity from NIH: G-protein-coupled receptor antagonists
Read More
Licensing opportunity from the NIH: method of inhibiting HGF/SF cleavage, activation
Read More
Millennium succeeds in identifying sixth antibacterial target in Wyeth-Ayerst alliance
Read More
Highly potent H3 receptor antagonist with potential therapeutic use
Read More
Dutch research group focuses attention on adenosine A3 receptor ligands
Read More
Ribozyme oligonucleotides against apo(a) as novel therapeutic strategy for cardiovascular diseases
Read More
Reduction in the incidence of dementia obtained with antihypertensive treatment
Read More
Eisai to collaborate with Toyama in development, marketing of DMARD
Read More
Pfizer and Hoechst Marion Roussel reach agreement for worldwide development of inhaled insulin
Read More
Zadaxin plus famciclovir provides surprising synergistic efficacy against HBV
Read More
Enzyme formulation for pancreatic insufficiency enters preclinical development at Altus
Read More
